Household & Personal Products
Compare Stocks
4 / 10Stock Comparison
NUS vs EL vs COTY vs IFF
Revenue, margins, valuation, and 5-year total return — side by side.
Household & Personal Products
Household & Personal Products
Chemicals - Specialty
NUS vs EL vs COTY vs IFF — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||||
|---|---|---|---|---|
| Industry | Household & Personal Products | Household & Personal Products | Household & Personal Products | Chemicals - Specialty |
| Market Cap | $345M | $30.80B | $2.20B | $19.99B |
| Revenue (TTM) | $1.49B | $14.84B | $5.79B | $10.79B |
| Net Income (TTM) | $160M | $-248M | $-536M | $839M |
| Gross Margin | 69.4% | 74.7% | 61.9% | 35.1% |
| Operating Margin | 4.4% | 6.8% | -0.3% | 8.0% |
| Forward P/E | 7.0x | 38.4x | 9.2x | 17.8x |
| Total Debt | $364M | $9.44B | $4.25B | $6.65B |
| Cash & Equiv. | $239M | $2.92B | $257M | $590M |
NUS vs EL vs COTY vs IFF — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Nu Skin Enterprises… (NUS) | 100 | 18.9 | -81.1% |
| The Estée Lauder Co… (EL) | 100 | 43.2 | -56.8% |
| Coty Inc. (COTY) | 100 | 68.9 | -31.1% |
| International Flavo… (IFF) | 100 | 58.8 | -41.2% |
Price return only. Dividends and distributions are not included.
Quick Verdict: NUS vs EL vs COTY vs IFF
Each card shows where this stock fits in a portfolio — not just who wins on paper.
NUS carries the broadest edge in this set and is the clearest fit for income & stability.
- Dividend streak 0 yrs, beta 1.49, yield 3.4%
- Lower P/E (7.0x vs 17.8x)
- 10.8% margin vs COTY's -9.3%
- 3.4% yield, vs COTY's 0.6%
EL is the #2 pick in this set and the best alternative if long-term compounding is your priority.
- 10.8% 10Y total return vs IFF's -12.6%
- +46.3% vs COTY's -45.3%
COTY is the clearest fit if your priority is growth exposure.
- Rev growth -3.7%, EPS growth -6.1%, 3Y rev CAGR 3.6%
- -3.7% revenue growth vs NUS's -14.3%
IFF is the clearest fit if your priority is sleep-well-at-night and defensive.
- Lower volatility, beta 0.68, Low D/E 46.9%, current ratio 1.42x
- Beta 0.68, yield 2.0%, current ratio 1.42x
- Beta 0.68 vs EL's 1.73, lower leverage
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | -3.7% revenue growth vs NUS's -14.3% | |
| Value | Lower P/E (7.0x vs 17.8x) | |
| Quality / Margins | 10.8% margin vs COTY's -9.3% | |
| Stability / Safety | Beta 0.68 vs EL's 1.73, lower leverage | |
| Dividends | 3.4% yield, vs COTY's 0.6% | |
| Momentum (1Y) | +46.3% vs COTY's -45.3% | |
| Efficiency (ROA) | 11.3% ROA vs COTY's -4.7%, ROIC 7.3% vs 2.3% |
NUS vs EL vs COTY vs IFF — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
NUS vs EL vs COTY vs IFF — Financial Metrics
Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
NUS leads in 2 of 6 categories
IFF leads 2 • EL leads 1 • COTY leads 0 • 1 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
EL leads this category, winning 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
EL is the larger business by revenue, generating $14.8B annually — 10.0x NUS's $1.5B. NUS is the more profitable business, keeping 10.8% of every revenue dollar as net income compared to COTY's -9.3%. On growth, EL holds the edge at +4.6% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||||
|---|---|---|---|---|
| RevenueTrailing 12 months | $1.5B | $14.8B | $5.8B | $10.8B |
| EBITDAEarnings before interest/tax | $118M | $1.6B | $314M | $1.7B |
| Net IncomeAfter-tax profit | $160M | -$248M | -$536M | $839M |
| Free Cash FlowCash after capex | $46M | $1.3B | $311M | $400M |
| Gross MarginGross profit ÷ Revenue | +69.4% | +74.7% | +61.9% | +35.1% |
| Operating MarginEBIT ÷ Revenue | +4.4% | +6.8% | -0.3% | +8.0% |
| Net MarginNet income ÷ Revenue | +10.8% | -1.7% | -9.3% | +7.8% |
| FCF MarginFCF ÷ Revenue | +3.1% | +8.7% | +5.4% | +3.7% |
| Rev. Growth (YoY)Latest quarter vs prior year | -16.9% | +4.6% | -1.3% | -3.6% |
| EPS Growth (YoY)Latest quarter vs prior year | +139.7% | -45.5% | 0.0% | +116.6% |
Valuation Metrics
NUS leads this category, winning 5 of 6 comparable metrics.
Valuation Metrics
On an enterprise value basis, NUS's 3.3x EV/EBITDA is more attractive than EL's 20.9x.
| Metric | ||||
|---|---|---|---|---|
| Market CapShares × price | $345M | $30.8B | $2.2B | $20.0B |
| Enterprise ValueMkt cap + debt − cash | $471M | $37.3B | $6.2B | $26.1B |
| Trailing P/EPrice ÷ TTM EPS | 2.21x | -27.08x | -5.68x | -53.60x |
| Forward P/EPrice ÷ next-FY EPS est. | 7.02x | 38.44x | 9.16x | 17.84x |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | — |
| EV / EBITDAEnterprise value multiple | 3.29x | 20.88x | 9.36x | 13.28x |
| Price / SalesMarket cap ÷ Revenue | 0.23x | 2.16x | 0.37x | 1.84x |
| Price / BookPrice ÷ Book value/share | 0.44x | 7.95x | 0.55x | 1.41x |
| Price / FCFMarket cap ÷ FCF | 7.50x | 45.97x | 7.93x | 78.09x |
Profitability & Efficiency
NUS leads this category, winning 9 of 9 comparable metrics.
Profitability & Efficiency
NUS delivers a 20.4% return on equity — every $100 of shareholder capital generates $20 in annual profit, vs $-14 for COTY. NUS carries lower financial leverage with a 0.45x debt-to-equity ratio, signaling a more conservative balance sheet compared to EL's 2.44x. On the Piotroski fundamental quality scale (0–9), NUS scores 6/9 vs EL's 4/9, reflecting solid financial health.
| Metric | ||||
|---|---|---|---|---|
| ROE (TTM)Return on equity | +20.4% | -6.3% | -14.1% | +5.9% |
| ROA (TTM)Return on assets | +11.3% | -1.3% | -4.7% | +3.3% |
| ROICReturn on invested capital | +7.3% | +6.5% | +2.3% | +3.5% |
| ROCEReturn on capital employed | +7.9% | +6.3% | +2.6% | +4.4% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 4 | 5 | 5 |
| Debt / EquityFinancial leverage | 0.45x | 2.44x | 1.07x | 0.47x |
| Net DebtTotal debt minus cash | $126M | $6.5B | $4.0B | $6.1B |
| Cash & Equiv.Liquid assets | $239M | $2.9B | $257M | $590M |
| Total DebtShort + long-term debt | $364M | $9.4B | $4.2B | $6.7B |
| Interest CoverageEBIT ÷ Interest expense | 15.14x | 1.14x | 0.23x | 5.26x |
Total Returns (Dividends Reinvested)
IFF leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in IFF five years ago would be worth $6,190 today (with dividends reinvested), compared to $2,002 for NUS. Over the past 12 months, EL leads with a +46.3% total return vs COTY's -45.3%. The 3-year compound annual growth rate (CAGR) favors IFF at -4.6% vs COTY's -40.9% — a key indicator of consistent wealth creation.
| Metric | ||||
|---|---|---|---|---|
| YTD ReturnYear-to-date | -26.9% | -19.8% | -19.6% | +15.6% |
| 1-Year ReturnPast 12 months | +26.3% | +46.3% | -45.3% | +8.5% |
| 3-Year ReturnCumulative with dividends | -77.1% | -55.6% | -79.4% | -13.2% |
| 5-Year ReturnCumulative with dividends | -80.0% | -68.3% | -75.8% | -38.1% |
| 10-Year ReturnCumulative with dividends | -48.8% | +10.8% | -83.0% | -12.6% |
| CAGR (3Y)Annualised 3-year return | -38.9% | -23.7% | -40.9% | -4.6% |
Risk & Volatility
IFF leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
IFF is the less volatile stock with a 0.68 beta — it tends to amplify market swings less than EL's 1.73 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. IFF currently trades 93.0% from its 52-week high vs COTY's 46.8% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||||
|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.49x | 1.73x | 1.08x | 0.68x |
| 52-Week HighHighest price in past year | $14.62 | $121.64 | $5.34 | $84.19 |
| 52-Week LowLowest price in past year | $5.65 | $57.91 | $1.96 | $59.14 |
| % of 52W HighCurrent price vs 52-week peak | +48.0% | +70.1% | +46.8% | +93.0% |
| RSI (14)Momentum oscillator 0–100 | 46.4 | 66.6 | 70.6 | 72.5 |
| Avg Volume (50D)Average daily shares traded | 458K | 4.6M | 7.9M | 1.6M |
Analyst Outlook
Evenly matched — NUS and COTY each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: NUS as "Hold", EL as "Hold", COTY as "Hold", IFF as "Buy". Consensus price targets imply 60.4% upside for COTY (target: $4) vs 12.1% for IFF (target: $88). For income investors, NUS offers the higher dividend yield at 3.35% vs COTY's 0.61%.
| Metric | ||||
|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | Hold | Hold | Buy |
| Price TargetConsensus 12-month target | $11.00 | $106.73 | $4.01 | $87.75 |
| # AnalystsCovering analysts | 11 | 46 | 33 | 33 |
| Dividend YieldAnnual dividend ÷ price | +3.4% | +2.0% | +0.6% | +2.0% |
| Dividend StreakConsecutive years of raises | 0 | 0 | 1 | 0 |
| Dividend / ShareAnnual DPS | $0.24 | $1.72 | $0.02 | $1.60 |
| Buyback YieldShare repurchases ÷ mkt cap | +5.8% | +0.1% | 0.0% | +0.2% |
NUS leads in 2 of 6 categories (Valuation Metrics, Profitability & Efficiency). IFF leads in 2 (Total Returns, Risk & Volatility). 1 tied.
NUS vs EL vs COTY vs IFF: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is NUS or EL or COTY or IFF a better buy right now?
For growth investors, Coty Inc.
(COTY) is the stronger pick with -3. 7% revenue growth year-over-year, versus -14. 3% for Nu Skin Enterprises, Inc. (NUS). Nu Skin Enterprises, Inc. (NUS) offers the better valuation at 2. 2x trailing P/E (7. 0x forward), making it the more compelling value choice. Analysts rate International Flavors & Fragrances Inc. (IFF) a "Buy" — based on 33 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — NUS or EL or COTY or IFF?
On forward P/E, Nu Skin Enterprises, Inc.
is actually cheaper at 7. 0x.
03Which is the better long-term investment — NUS or EL or COTY or IFF?
Over the past 5 years, International Flavors & Fragrances Inc.
(IFF) delivered a total return of -38. 1%, compared to -80. 0% for Nu Skin Enterprises, Inc. (NUS). Over 10 years, the gap is even starker: EL returned +10. 8% versus COTY's -83. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — NUS or EL or COTY or IFF?
By beta (market sensitivity over 5 years), International Flavors & Fragrances Inc.
(IFF) is the lower-risk stock at 0. 68β versus The Estée Lauder Companies Inc. 's 1. 73β — meaning EL is approximately 155% more volatile than IFF relative to the S&P 500. On balance sheet safety, Nu Skin Enterprises, Inc. (NUS) carries a lower debt/equity ratio of 45% versus 2% for The Estée Lauder Companies Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — NUS or EL or COTY or IFF?
By revenue growth (latest reported year), Coty Inc.
(COTY) is pulling ahead at -3. 7% versus -14. 3% for Nu Skin Enterprises, Inc. (NUS). On earnings-per-share growth, the picture is similar: Nu Skin Enterprises, Inc. grew EPS 207. 8% year-over-year, compared to -609. 8% for Coty Inc.. Over a 3-year CAGR, COTY leads at 3. 6% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — NUS or EL or COTY or IFF?
Nu Skin Enterprises, Inc.
(NUS) is the more profitable company, earning 10. 8% net margin versus -7. 9% for The Estée Lauder Companies Inc. — meaning it keeps 10. 8% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: IFF leads at 9. 2% versus 4. 1% for COTY. At the gross margin level — before operating expenses — EL leads at 73. 9%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is NUS or EL or COTY or IFF more undervalued right now?
On forward earnings alone, Nu Skin Enterprises, Inc.
(NUS) trades at 7. 0x forward P/E versus 38. 4x for The Estée Lauder Companies Inc. — 31. 4x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for COTY: 60. 4% to $4. 01.
08Which pays a better dividend — NUS or EL or COTY or IFF?
All stocks in this comparison pay dividends.
Nu Skin Enterprises, Inc. (NUS) offers the highest yield at 3. 4%, versus 0. 6% for Coty Inc. (COTY).
09Is NUS or EL or COTY or IFF better for a retirement portfolio?
For long-horizon retirement investors, International Flavors & Fragrances Inc.
(IFF) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 68), 2. 0% yield). The Estée Lauder Companies Inc. (EL) carries a higher beta of 1. 73 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (IFF: -12. 6%, EL: +10. 8%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between NUS and EL and COTY and IFF?
These companies operate in different sectors (NUS (Consumer Defensive) and EL (Consumer Defensive) and COTY (Consumer Defensive) and IFF (Basic Materials)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: NUS is a small-cap deep-value stock; EL is a mid-cap quality compounder stock; COTY is a small-cap quality compounder stock; IFF is a mid-cap quality compounder stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.